Julia Weiss
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Julia Weiss has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Afshin Gangi
Department of Interventional Radiology, University Hospital Strasbourg, Strasbourg, France
3 shared publications - Roberto Luigi Cazzato
Department of Interventional Radiology, University Hospital Strasbourg, Strasbourg, France
3 shared publications - Guillaume Koch
Department of Interventional Radiology, University Hospital Strasbourg, Strasbourg, France
2 shared publications - Jean Caudrelier
Service D’Imagerie Interventionnelle, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
2 shared publications - Pierre-Alexis Autrusseau
Service de Radiologie, Centre de Lutte Contre le Cancer, Institut Strauss, 67200 Strasbourg, France
2 shared publications - Aline Host
Department of Gynecology and Obstetrics, Hopitaux Universitaires de Strasbourg, Strasbourg, France
1 shared publication
Latest Publications
- Open Access
Adjunctive Techniques for Optimizing Percutaneous CT-Guided Cryoablation of Renal Tumours
Percutaneous computed tomography (CT) -guided cryoablation is an effective curative treatment for renal cell carcinoma. Improvements in treatment efficacy reflect not only the learning curve but also the integration of multiple adjunctive techniques that can be implemented at different stages of the procedure. Tumour targeting can be enhanced by intravenous contrast administration, or by intra-arterial delivery of contrast medium or iodized oil. Fusion imaging is another option to improve tumour delineation by registering intraprocedural CT with prior cross-sectional imaging. Probe placement for difficult-to-access lesions may be facilitated by alternative access routes, while electromagnetic navigation and robotic systems are being developed as alternatives to manual advancement. To mitigate the cold-sink effect and reduce bleeding risk, transarterial techniques such as embolization or temporary arterial occlusion can be added. Finally, thermoprotective manoeuvres are increasingly used to displace adjacent organs, thereby improving the feasibility, safety, and efficacy of renal cryoablation.
Open AccessAdjunctive Techniques for Optimizing Percutaneous CT-Guided Cryoablation of Renal Tumours
Percutaneous computed tomography (CT) -guided cryoablation is an effective curative treatment for renal cell carcinoma. Improvements in treatment efficacy reflect not only the learning curve but also the integration of multiple adjunctive techniques that can be implemented at different stages of the procedure. Tumour targeting can be enhanced by intravenous contrast administration, or by intra-arterial delivery of contrast medium or iodized oil. Fusion imaging is another option to improve tumour delineation by registering intraprocedural CT with prior cross-sectional imaging. Probe placement for difficult-to-access lesions may be facilitated by alternative access routes, while electromagnetic navigation and robotic systems are being developed as alternatives to manual advancement. To mitigate the cold-sink effect and reduce bleeding risk, transarterial techniques such as embolization or temporary arterial occlusion can be added. Finally, thermoprotective manoeuvres are increasingly used to displace adjacent organs, thereby improving the feasibility, safety, and efficacy of renal cryoablation.
- 19 March 2025
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 48 (4) , 543-550
Percutaneous Image-Guided Cryoablation of Endometriosis Scars in Unusual Anatomic Locations
Purpose To report the pain relief and procedure-related outcomes of percutaneous cryoablation (CA) of painful endometriosis deposits in unusual anatomic locations. Materials and Methods A retrospective search of institutional radiological information system identified a total of 15 patients (median age 35.5 years; interquartile ranges—IQR 33–38). Patients and lesions specific data as well as procedural and follow-up information were collected, analyzed, and presented using descriptive statistical methods. Results A total of 16 painful target lesions situated in the umbilicus (7/16; 43.8%), diaphragm (4/16; 25.0%), inguinal canal (3/16; 18.8%), and within the muscular layers of the uterus (i.e., adenomyosis; 2/16; 12.4%) underwent CA. The median of the largest diameter of the target lesions was 19 mm (IQR 13–22.3). Primary and secondary rates of complete pain relief were achieved in 86.7% (13/15 patients) and 93.3% (14/15 patients; one patient receiving additional CA for recurring pain) of patients, respectively. Each lesion underwent one single intervention, thus accounting for a total of 16 CA procedures. Eleven interventions were carried out under general anesthesia (11/16; 68.8%), with combination of ultrasound and cross-sectional imaging (CT or MRI) being the most used modality for image guidance (10/16; 62.5%). Nearly all interventions (15/16; 93.8%) required adjunctive protective measures with hydrodissection (13/16; 81.3%) and combination of hydrodissection and cutaneous protection with warm saline filled gloves (9/16; 56.3%) being the two most common protective measures. Two (2/16; 12.5%) complications were noted. Conclusions Percutaneous CA of painful endometriosis deposits in unusual anatomic locations seems highly effective and safe. Graphical Abstract
- 19 March 2025
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 48 (4) , 543-550
Percutaneous Image-Guided Cryoablation of Endometriosis Scars in Unusual Anatomic Locations
Purpose To report the pain relief and procedure-related outcomes of percutaneous cryoablation (CA) of painful endometriosis deposits in unusual anatomic locations. Materials and Methods A retrospective search of institutional radiological information system identified a total of 15 patients (median age 35.5 years; interquartile ranges—IQR 33–38). Patients and lesions specific data as well as procedural and follow-up information were collected, analyzed, and presented using descriptive statistical methods. Results A total of 16 painful target lesions situated in the umbilicus (7/16; 43.8%), diaphragm (4/16; 25.0%), inguinal canal (3/16; 18.8%), and within the muscular layers of the uterus (i.e., adenomyosis; 2/16; 12.4%) underwent CA. The median of the largest diameter of the target lesions was 19 mm (IQR 13–22.3). Primary and secondary rates of complete pain relief were achieved in 86.7% (13/15 patients) and 93.3% (14/15 patients; one patient receiving additional CA for recurring pain) of patients, respectively. Each lesion underwent one single intervention, thus accounting for a total of 16 CA procedures. Eleven interventions were carried out under general anesthesia (11/16; 68.8%), with combination of ultrasound and cross-sectional imaging (CT or MRI) being the most used modality for image guidance (10/16; 62.5%). Nearly all interventions (15/16; 93.8%) required adjunctive protective measures with hydrodissection (13/16; 81.3%) and combination of hydrodissection and cutaneous protection with warm saline filled gloves (9/16; 56.3%) being the two most common protective measures. Two (2/16; 12.5%) complications were noted. Conclusions Percutaneous CA of painful endometriosis deposits in unusual anatomic locations seems highly effective and safe. Graphical Abstract
- 28 August 2024
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 48 (1) , 84-93
Combination of Elastic Nail(s) and Cementoplasty to Treat Pathological Fractures in Long Bones of the Upper Limb
- 28 August 2024
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 48 (1) , 84-93
Combination of Elastic Nail(s) and Cementoplasty to Treat Pathological Fractures in Long Bones of the Upper Limb
- 11 March 2021
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 26 (6) , 1147-1158
Percutaneous cryoablation for advanced and refractory extra-abdominal desmoid tumors
Purpose To assess efficacy and safety of percutaneous cryoablation (CA) for advanced and refractory extra-abdominal desmoid tumors. Materials and methods This retrospective study reviewed 30 consecutive patients with symptomatic desmoid tumors evolving after “wait and watch” periods, and despite medical treatment, treated by CA between 2007 and 2019. Progression free survival (PFS), objective response rate, pain reduction (decreased of visual analogic scale pain (VAS)\(\ge\) 3 or disappearance of pain), total volume lesion (TVL) and complications were documented. Kaplan Meier method was used to outline PFS. Paired sample t test was used to compare volume of tumors before treatment and at 1 and 3 year. Results With a median follow-up of 18.5 months (range 6–93 months, interquartile range (IQR): 12–55), the PFS was 85.1% at 1 year and 77.3% at 3 years. Objective response was obtained for 80% of patients with a complete response for 43% patients. Pain reduction was obtained for 96.7% (95% confidence interval (95% CI): 90.3, 100) of patients. Median volume of desmoid tumor before treatment was 124.1cm3 (range 2–1727cm3, IQR: 54–338cm3). Median change of TLV after ablation was 66.6% (95% CI: 37.2, 72.3; p = 0.002) at 1 year and 76.4% (95% CI: 59.1, 89.8; p = 0.002) at 3 year. Adverse events rate was 36.6%, the most common was edema and temporary increase of pain in the days following CA. Four patients experienced a major complication (13.3%): 2 skin necrosis, 1 infection and 1 brachial plexopathy. Conclusion CA is an effective treatment for advanced and refractory extra-abdominal desmoid tumor, that induces durable responses.- 11 March 2021
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 26 (6) , 1147-1158
Percutaneous cryoablation for advanced and refractory extra-abdominal desmoid tumors
Purpose To assess efficacy and safety of percutaneous cryoablation (CA) for advanced and refractory extra-abdominal desmoid tumors. Materials and methods This retrospective study reviewed 30 consecutive patients with symptomatic desmoid tumors evolving after “wait and watch” periods, and despite medical treatment, treated by CA between 2007 and 2019. Progression free survival (PFS), objective response rate, pain reduction (decreased of visual analogic scale pain (VAS)\(\ge\) 3 or disappearance of pain), total volume lesion (TVL) and complications were documented. Kaplan Meier method was used to outline PFS. Paired sample t test was used to compare volume of tumors before treatment and at 1 and 3 year. Results With a median follow-up of 18.5 months (range 6–93 months, interquartile range (IQR): 12–55), the PFS was 85.1% at 1 year and 77.3% at 3 years. Objective response was obtained for 80% of patients with a complete response for 43% patients. Pain reduction was obtained for 96.7% (95% confidence interval (95% CI): 90.3, 100) of patients. Median volume of desmoid tumor before treatment was 124.1cm3 (range 2–1727cm3, IQR: 54–338cm3). Median change of TLV after ablation was 66.6% (95% CI: 37.2, 72.3; p = 0.002) at 1 year and 76.4% (95% CI: 59.1, 89.8; p = 0.002) at 3 year. Adverse events rate was 36.6%, the most common was edema and temporary increase of pain in the days following CA. Four patients experienced a major complication (13.3%): 2 skin necrosis, 1 infection and 1 brachial plexopathy. Conclusion CA is an effective treatment for advanced and refractory extra-abdominal desmoid tumor, that induces durable responses.